Related Experiment Videos
[Multiple sclerosis in northwestern Switzerland].
W Groebke-Lorenz1, S Balint, U P Frey
1Neurologische Universitätsklinik, Kantonsspital Basel.
Schweizerische Medizinische Wochenschrift
|April 18, 1992
Summary
This study surveyed multiple sclerosis (MS) in Switzerland from 1980-1987, finding a prevalence of 142/100,000 and estimating over 8000 cases. MS affects more women, with onset around age 31 and a 30-year survival rate.
Area of Science:
- Epidemiology
- Neurology
Context:
- A comprehensive epidemiologic survey was conducted in northwestern Switzerland between 1980 and 1987.
- The study aimed to identify and register the maximum number of Multiple Sclerosis (MS) cases within a defined population of 523,000.
Purpose:
- To determine the prevalence and incidence of Multiple Sclerosis (MS) in northwestern Switzerland.
- To gather data on key epidemiological characteristics of MS, including age at onset, sex distribution, and survival rates.
Summary:
- The survey revealed an overall MS prevalence of 142 per 100,000 population, with a peak of 164/100,000 in Basle.
- An estimated 8000+ MS patients reside in Switzerland, with a female-to-male ratio of 2.2:1.
- The mean age of clinical onset was 31.6 years, and the mean survival was 30.6 years.
Impact:
- Findings indicate a growing MS prevalence, primarily attributed to increased patient survival and demographic shifts.
- The study provides crucial epidemiological data for understanding MS burden and informing public health strategies in Switzerland.
- Results suggest stable MS incidence despite rising prevalence, highlighting the impact of improved management and survival.